Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 1.00 |
| ▸ | CCR8 | P51685 | 2/20 | 1.00 |
| ▸ | METAP2 | P50579 | 1/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | NOS3 | P29474 | 1/20 | 0.55 |
| ▸ | NOS2 | P35228 | 1/20 | 0.55 |
| ▸ | TGFBR1 | P36897 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CCR5 | P51681 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388304 | 1.00 | CCR1 (1.00) | CCR1CCR8METAP2CYP2A6NOS3 | |
| SCHEMBL30511194 | 1.00 | CCR1 (1.00) | CCR1CCR8METAP2CYP2A6NOS3 | |
| SCHEMBL29751933 | 0.97 | CCR1 (0.94) | CCR1CCR8METAP2CYP2A6NOS3 | |
| SCHEMBL3422291 | 0.97 | CCR1 (0.94) | CCR1CCR8METAP2CYP2A6NOS3 | |
| SCHEMBL29751919 | 0.97 | CCR1 (0.94) | CCR1CCR8METAP2CYP2A6NOS3 | |
| SCHEMBL20557390 | 0.97 | CCR1 (0.94) | CCR1CCR8METAP2CYP2A6NOS3 | |
| SCHEMBL3423401 | 0.97 | CCR1 (0.94) | CCR1CCR8METAP2CYP2A6NOS3 | |
| Hydrochloric Acid SCHEMBL2410509 | 0.94 | CCR1 (0.89) | CCR1CCR8METAP2CYP2A6NOS3 | |
| Bromide SCHEMBL4388984 | 0.94 | CCR1 (0.89) | CCR1CCR8METAP2CYP2A6NOS3 | |
| Iodide SCHEMBL4384044 | 0.94 | CCR1 (0.89) | CCR1CCR8METAP2CYP2A6NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 785 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250375458-A1 | COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES | THERALASE TECH INC (CA) | 2025-12-11 | — | — | US | claimed |
| US-20250375511-A1 | METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS | THERALASE TECH INC (CA) | 2025-12-11 | — | — | US | claimed |
| US-20250114456-A1 | ENHANCED IMMUNOTHERAPEUTIC METHOD COMPRISING COMBINED ADMINISTRATION OF PHOTODYNAMIC / RADIOTHERAPEUTIC COMPOUNDS AND IMMUNOTHERAPEUTIC AGENTS | THERALASE TECHNOLOGIES, INC. (CA) | 2025-04-10 | — | — | US | claimed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | claimed |
| CN-117894971-B | Glassy metal organic framework material modified ternary positive electrode material, and preparation method and application thereof | 中南大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117867526-A | Preparation method of 2-deuterium-1, 2-diphenylethane derivative | 五邑大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117229234-A | Preparation method of gamma-oxo ester and/or amide | 中国科学院大连化学物理研究所 | 2023-12-15 | — | — | CN | claimed |
| CN-117229235-A | Novel preparation method of naftidroflumilast | 中国科学院大连化学物理研究所 | 2023-12-15 | — | — | CN | claimed |
| CN-116925012-A | Preparation method of alpha-ester ether | 中国科学院大连化学物理研究所 | 2023-10-24 | — | — | CN | claimed |
| CN-114853568-B | Preparation method of 4, 5-pentafluoropentanol | 辽宁孚音生物科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| US-20100216988-A1 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | SANOFI-AVENTIS (FR) | 2010-08-26 | — | — | US | claimed |
| EP-2173721-A1 | A REGIOSELECTIVE COPPER CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES | Sanofi-Aventis (FR) | 2010-04-14 | — | — | EP | claimed |
| EP-2173747-A1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | Sanofi-Aventis (FR) | 2010-04-14 | — | — | EP | claimed |
| WO-2009000413-A1 | A REGIOSELECTIVE COPPER CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES | SANOFI-AVENTIS (FR) | 2008-12-31 | — | — | WO | claimed |
| WO-2009000412-A1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | SANOFI AVENTIS (FR) | 2008-12-31 | — | — | WO | claimed |
| US-7238832-B2 | Production method of a coupling compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-03 | — | — | US | claimed |
| EP-1449580-B1 | Production method of a cross-coupling compound from an alkyl halide and an organoboron compound | SUMITOMO CHEMICAL CO (JP) | 2005-12-28 | — | — | EP | claimed |
| US-20040167364-A1 | Production method of a coupling compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-08-26 | — | — | US | claimed |
| EP-1449580-A1 | Production method of a cross-coupling compound from an alkyl halide and an organoboron compound | Sumitomo Chemical Co.,Ltd. (JP) | 2004-08-25 | — | — | EP | claimed |
| WO-2000053642-A1 | CONTROLLED (CO)POLYMERISATION WITH N-HETEROCYCLES METAL COMPLEX SYSTEMS | SCHUBERT ULRICH S (DE) | 2000-09-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375458-A1 | COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES | CD4, TPMT, SLC11A2 | CCR1 70/4885CCR8 193/4885METAP2 1883/4885 |
| US-20250114456-A1 | ENHANCED IMMUNOTHERAPEUTIC METHOD COMPRISING COMBINED ADMINISTRATION OF PHOTODYNAMIC / RADIOTHERAPEUTIC COMPOUNDS AND IMMUNOTHERAPEUTIC AGENTS | PDCD1, CD47, CD274 | CCR1 471/4885CCR8 903/4885METAP2 158/4885 |
| US-20040167364-A1 | Production method of a coupling compound | PYM1, BRIX1, CXCR1 | CCR1 94/4885CCR8 1500/4885METAP2 2894/4885 |
| US-20250375511-A1 | METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS | NFATC1, PCNA, PHPT1 | CCR1 2081/4885CCR8 3297/4885METAP2 396/4885 |
| US-20100216988-A1 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | AZI2, NIT2, NISCH | CCR1 3957/4885CCR8 4506/4885METAP2 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.